Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Aflibercept biosimilar by Lupin for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Aflibercept biosimilar is under clinical development by Lupin and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....
Data Insights
Denosumab biosimilar by Lupin for Post Menopausal Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Lupin and currently in Phase III for Post Menopausal Osteoporosis. According to GlobalData,...